| Description: |
In a new study, more than two-thirds of people with a rare type of melanoma responded positively to treatment with anti-PD-1 immunotherapies. The findings counter the conventional wisdom that a cancer which is highly fibrotic with dense stroma could not respond to immunotherapy, and have the potential to help scientists identify those patients most likely to benefit from treatment. [Source: ScienceDaily]
|
 |
